Sr. Manager, Strategy - Oncology & Multispecialty

McKesson Corporation; Irving (TX); Hybrid; USD 140,000 - 190,000; Full time

Job summary

McKesson Corporation is seeking a Sr. Manager, Strategy - Oncology & Multispecialty to drive analytical frameworks, models, and research that enable the evaluation and execution of key strategic initiatives.

This role spans provider-facing and biopharma-facing segments and sits at their intersection to address distinctive strategic questions. The role offers location flexibility and is open to candidates across the United States, with Dallas–Fort Worth area hybrid onsite two days per week at the

Responsibilities

• The Sr. Manager will be expected

Job description

McKesson is an impact-driven, Fortune 10 company that touches virtually every aspect of healthcare. We are known for delivering insights, products, and services that make quality care more accessible and affordable. Here, we focus on the health, happiness, and well-being of you and those we serve - we care.

What you do at McKesson matters. We foster a culture where you can grow, make an impact, and are empowered to bring new ideas. Together, we thrive as we shape the future of health for patients, our communities, and our people. If you want to be part of tomorrow's health today, we want to hear from you.

This role offers location flexibility and is open to candidates across the United States.

Candidates based in the Dallas-Fort Worth (DFW) area will be hired in a hybrid capacity and are expected to work onsite at our Las Colinas office a minimum of two (2) days per week, with the remaining days worked remotely. Specific in office days may be designated based on team needs and business priorities.

About The Role:

The Sr. Manager, Strategy - Oncology & Multispecialty is an analytical individual contributor role within the strategy team, supportingthe developmentofframeworks, models, and researchthat enable the evaluation and execution of key strategicinitiatives.Initiatives spanbothcommercial segments - provider-facing (GPO, specialty distribution, specialty pharmacy, alternate site infusion, practice management) and biopharma-facing (clinical trial site management, real-world evidence, clinicogenomic data) - and frequently sit at the intersection between the two, where the segment's most distinctive strategic questions live.

The Sr. Manager will be expected